|
|
Exchange: |
American Stock Exchange |
Security
Type: |
Common |
Shares
Out: |
9,860,000 |
Market
Cap: |
4.34(M) |
Last
Volume: |
343,990 |
Avg
Vol: |
276,246 |
52
Week Range: |
$0.258 - $0.5 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Titan Pharmaceuticals is a pharmaceutical company developing therapeutics utilizing its drug delivery platform, ProNeura, for the treatment of select chronic diseases. Probuphine is a product based on its ProNeura technology approved in the United States, Canada and the European Union, for the maintenance treatment of opioid use disorder (OUD). Co. is conducting non-clinical studies with a nalmefene implant for the potential treatment of OUD under a grant from the National Institutes of Health. Co. is collaborating with the Walter Reed Army Institute of Research and South West Research Institute in the early non-clinical evaluation of the ProNeura platform in malaria prophylaxis.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
57,500 |
Total Buy Value |
$0 |
$0 |
$0 |
$56,287 |
Total People Bought |
0 |
0 |
0 |
1 |
Total Buy Transactions |
0 |
0 |
0 |
2 |
Total Shares Sold |
0 |
0 |
0 |
3,747,968 |
Total Sell Value |
$0 |
$0 |
$0 |
$4,610,000 |
Total People Sold |
0 |
0 |
0 |
1 |
Total Sell Transactions |
0 |
0 |
0 |
2 |
End Date |
2024-06-27 |
2024-03-26 |
2023-09-26 |
2022-09-26 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Bhonsle Sunil |
President |
|
2014-10-13 |
4 |
B |
$0.47 |
$43,240 |
D/D |
92,000 |
356,500 |
2.81 |
- |
|
Bhonsle Sunil |
President |
|
2014-10-10 |
4 |
B |
$0.49 |
$11,688 |
D/D |
24,000 |
0 |
2.81 |
- |
|
Rubin Marc |
Executive Chairman |
|
2014-10-09 |
4 |
B |
$0.48 |
$48,200 |
D/D |
100,000 |
707,200 |
2.81 |
- |
|
Bhonsle Sunil |
President |
|
2014-10-09 |
4 |
B |
$0.48 |
$47,800 |
D/D |
100,000 |
0 |
2.81 |
- |
|
Rubin Marc |
Executive Chairman |
|
2014-02-12 |
4 |
A |
$0.66 |
$66,000 |
D/D |
100,000 |
682,200 |
|
- |
|
Bhonsle Sunil |
President |
|
2014-02-12 |
4 |
A |
$0.66 |
$66,000 |
D/D |
100,000 |
215,500 |
|
- |
|
Harrison Seth Loring |
10% Owner |
|
2013-11-25 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
9,650,000 |
|
- |
|
Bhonsle Sunil |
President |
|
2013-06-18 |
4 |
B |
$0.46 |
$22,770 |
D/D |
50,000 |
115,500 |
2.81 |
- |
|
Rubin Marc |
Executive Chairman |
|
2013-06-17 |
4 |
B |
$0.45 |
$22,690 |
D/D |
50,000 |
463,400 |
2.81 |
- |
|
Bhonsle Sunil |
President |
|
2013-02-25 |
4 |
OE |
$1.50 |
$75,000 |
D/D |
50,000 |
65,500 |
|
- |
|
Bauer Victor J Phd |
Director |
|
2013-02-25 |
4 |
OE |
$1.50 |
$37,500 |
D/D |
25,000 |
36,144 |
|
- |
|
Rubin Marc |
Executive Chairman |
|
2011-11-18 |
4 |
B |
$1.27 |
$48,918 |
D/D |
38,400 |
413,400 |
2.81 |
- |
|
Bhonsle Sunil |
President |
|
2011-11-18 |
4 |
B |
$1.32 |
$32,900 |
D/D |
25,000 |
65,500 |
2.81 |
- |
|
Kapp Joachim Friedrich |
Director |
|
2010-10-21 |
4 |
S |
$1.31 |
$148,554 |
D/D |
(113,400) |
546,339 |
|
- |
|
Kapp Joachim Friedrich |
Director |
|
2010-10-20 |
4 |
S |
$1.32 |
$128,476 |
D/D |
(97,700) |
0 |
|
- |
|
Kapp Joachim Friedrich |
Director |
|
2010-10-19 |
4 |
S |
$1.30 |
$19,403 |
D/D |
(14,925) |
0 |
|
- |
|
Kapp Joachim Friedrich |
Director |
|
2010-10-18 |
4 |
S |
$1.30 |
$33,783 |
D/D |
(25,987) |
0 |
|
- |
|
Kapp Joachim Friedrich |
Director |
|
2010-10-15 |
4 |
S |
$1.30 |
$51,298 |
D/D |
(39,460) |
0 |
|
- |
|
Kapp Joachim Friedrich |
Director |
|
2010-10-14 |
4 |
S |
$1.30 |
$236,269 |
D/D |
(181,188) |
0 |
|
- |
|
Kapp Joachim Friedrich |
Director |
|
2010-10-13 |
4 |
S |
$1.43 |
$122,894 |
D/D |
(86,000) |
0 |
|
- |
|
Cavaller Eurelio M |
Director |
|
2010-03-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
182,500 |
|
- |
|
Bhonsle Sunil |
PresidentOfficer |
|
2010-03-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
225,757 |
|
- |
|
Bhonsle Sunil |
PresidentOfficer |
|
2010-03-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
65,500 |
|
- |
|
Huckel Hubert E Md |
Director |
|
2010-03-15 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
789 |
|
- |
|
Huckel Hubert E Md |
Director |
|
2010-03-15 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
188,400 |
|
- |
|
131 Records found
|
|
Page 3 of 6 |
|
|